The role of platelet count and mean platelet volume in clopidogrel resistance in ischemic stroke patients [PDF]
E. Xanmemmedov +6 more
openalex +1 more source
Clopidogrel resistance in extremely high cardiovascular risk patients with genotype CYP2C19
Liliana Cárdenas +5 more
openalex +1 more source
Cairns, John A., Eikelboom, John
openaire +1 more source
Rescue of immediate post-transcarotid artery revascularization carotid stent thrombosis due to clopidogrel resistance using flow-reversal and aspiration thrombectomy. [PDF]
Lu J.
europepmc +1 more source
Comparison of a New P2Y12 Receptor Specific Platelet Aggregation Test with Other Laboratory Methods in Stroke Patients on Clopidogrel Monotherapy [PDF]
Bagoly, Zsuzsa +6 more
core +1 more source
Antithrombotic failure and aspirin and clopidogrel resistance [PDF]
James Waller, Derek G. Waller
openalex +1 more source
CYP2C19 polymorphisms and lipoproteins associated with clopidogrel resistance in children with Kawasaki disease in China: A prospective study. [PDF]
Zhang M, Meng L, Chen Y, Li X, Shi L.
europepmc +1 more source
Positive effect of low-activity thromboxane A synthase 1 gene on prognosis in coronary heart disease
Aim. To analyze the influence of pharmacogenetic factors on the risk of clopidogrel resistance and cardiovascular events during 18-months follow-up. Subjects and methods. Two hundred and fifty patients taking clopidogrel were examined.
F Yu Kopylov +6 more
doaj
Relationship between CYP2C19 Polymorphism and Clopidogrel Resistance in Patients with Coronary Heart Disease and Ischemic Stroke in China. [PDF]
Chang R +5 more
europepmc +1 more source
Clopidogrel discontinuation and platelet reactivity following coronary stenting. [PDF]
Aims: Antiplatelet therapy with aspirin and clopidogrel are recommended for 1 year after drug-eluting stent (DES) implantation or myocardial infarction. However, the discontinuation of antiplatelet therapy has become an important issue as recent studies ...
Dicker, Patrick +6 more
core +1 more source

